The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum β-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 3, 2007, Pages 349-355

  Kiratisin, Pattarachai ^a   Apisarnthanarak, Anucha ^b   Saifon, Piyawan ^a   Laesripa, Chaitat ^a   Kitphati, Rungrueng ^c   Mundy, Linda M ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

^c Thai National Institute of Health   (Thailand)

^d SAINT LOUIS UNIVERSITY   (United States)

Author keywords

ESBL; Escherichia coli; Extended spectrum lactamase; Klebsiella pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; PLASMID DNA; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CLINICAL ARTICLE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THAILAND; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAMASES; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA FINGERPRINTING; DNA, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; THAILAND;

EID: 34347325951     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.02.005     Document Type: Article

References (32)

1. Ambler R.P., Coulson A.F., Frere J.M., Ghuysen J.M., Joris B., Forsman M., Levesque R.C., Tiraby G., and Waley S.G. A standard numbering scheme for the class A beta-lactamases. Biochem. J. 276 (1991) 269-270
2. Apisarnthanarak A., Kiratisin P., Saifon P., Kitphati R., Dejsirilert S., and Mundy L.M. Risk factors and outcomes of community associated extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae in a tertiary care center in Thailand. Program and Abstract of the 16th Annual Meeting of Society for Healthcare Epidemiology of North America (SHEA), Chicago, IL (2006)
3. Apisarnthanarak A., Kiratisin P., Saifon P., Kitphati R., Dejsirilert S., and Mundy L.M. Risk factors and outcomes of healthcare associated extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae in a tertiary care center in Thailand. Program and Abstract of the 16th Annual Meeting of Society for Healthcare Epidemiology of North America (SHEA), Chicago, IL (2006)
4. Bae I.K., Lee B.H., Hwang H.Y., Jeong S.H., Hong S.G., Chang C.L., Kwak H.S., Kim H.J., and Youn H. A novel ceftazidime-hydrolysing extended-spectrum β-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop. J. Antimicrob. Chemother. 58 (2006) 315-319
5. Baraniak A., Fiett J., Hryniewicz W., Nordmann P., and Gniadkowski M. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland. J. Antimicrob. Chemother. 50 (2002) 393-396
6. Bauernfeind A., and Grimm H. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18 (1990) 294-298
7. Ben-Ami R., Schwaber M.J., Navon-Venezia S., Schwartz D., Giladi M., Chmelnitsky I., Leavitt A., and Carmeli Y. Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin. Infect. Dis. 42 (2006) 925-934
8. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48 (2004) 1-14
9. Bonnet R., Recule C., Baraduc R., Chanal C., Sirot D., De Champs C., and Sirot J. Effect of D240G substitution in a novel ESBL CTX-M-27. J. Antimicrob. Chemother. 52 (2003) 29-35
10. Calbo E., Romani V., Xercavins M., Gomez L., Vidal C.G., Quintana S., Vila J., and Garau J. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 57 (2006) 780-783
11. Cartelle M., del Mar Tomas M., Pertega S., Beceiro A., Dominguez M.A., Velasco D., Molina F., Villanueva R., and Bou G. Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins. J. Clin. Microbiol. 42 (2004) 4242-4249
12. Chandler M., and Hanillon J. Insertion sequences revisited. In: Craig N.L., Craigie R., Gellert M., and Lambowitz A.M. (Eds). Mobile DNA II (2002), ASM Press, Washington, DC 305-366
13. CLSI (Clinical Laboratory Standards Institute). Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement, M100-S16 (2006) Wayne, PA
14. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16 (1988) 128-140
15. Girlich D., Poirel L., Leelaporn A., Karim A., Tribuddharat C., Fennewald M., and Nordmann P. Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J. Clin. Microbiol. 39 (2001) 175-182
16. Gray K.J., Wilson L.K., Phiri A., Corkill J.E., French N., and Hart C.A. Identification and characterization of ceftriaxone resistance and extended-spectrum β-lactamases in Malawian bacteraemic Enterobacteriaceae. J. Antimicrob. Chemother. 57 (2006) 661-665
17. Heritage J., M'Zali F.H., Gascoyne-Binzi D., and Hawkey P.M. Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria. J. Antimicrob. Chemother. 44 (1999) 309-318
18. Hyle E.P., Lipworth A.D., Zaoutis T.E., Nachamkin I., Fishman N.O., Bilker W.B., Mao X., and Lautenbach E. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 40 (2005) 1317-1324
19. Karim A., Poirel L., Nagarajan S., and Nordmann P. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201 (2001) 237-241
20. Kaufmann M.E. Pulsed-field gel electrophoresis. In: Woodford N., and Johnson A.P. (Eds). Molecular Bacteriology: Protocols and Clinical Applications (1998), Humana Press, New Jersy 33-50
21. Lartigue M.F., Poirel L., and Nordmann P. Diversity of genetic environment of bla(CTX-M) genes. FEMS Microbiol. Lett. 15 (2004) 201-207
22. Pai H., Lyu S., Lee J.H., Kim J., Kwon Y., Kim J.W., and Choe K.W. Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J. Clin. Microbiol. 37 (1999) 1758-1763
23. Pitout J.D., Hanson N.D., Church D.L., and Laupland K.B. Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes. Clin. Infect. Dis. 38 (2004) 1736-1741
24. Poirel L., Naas T., Le Thomas I., Karim A., Bingen E., and Nordmann P. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob. Agents Chemother. 45 (2001) 3355-3361
25. Poirel L., Gniadkowski M., and Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. J. Antimicrob.Chemother. 50 (2002) 1031-1034
26. Poirel L., Decousser J.W., and Nordmann P. Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene. Antimicrob. Agents Chemother. 47 (2003) 2938-2945
27. Poirel L., Lartigue M.F., Decousser J.W., and Nordmann P. ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli. Antimicrob. Agents Chemother. 49 (2005) 447-450
28. Saladin M., Cao V.T., Lambert T., Donay J.L., Herrmann J.L., Ould-Hocine Z., Verdet C., Delisle F., Philippon A., and Arlet G. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett. 209 (2000) 161-168
29. Sturenburg E., Kuhn A., Mack D., and Laufs R. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance. J. Antimicrob. Chemother. 54 (2004) 406-409
30. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
31. Tzouvelekis L.S., and Bonomo R.A. SHV-type β-lactamases. Curr. Pharm. Des. 5 (1999) 847-864
32. Tzouvelekis L.S., Tzelepi E., Tassios P.T., and Legakis N.J. CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. Int. J. Antimicrob. Agents 14 (2000) 137-142